Regulation And Legal
Transgene Biotek SEBI Regulation 32(1) Non-Applicability Intimation
Transgene Biotek intimates BSE that SEBI Regulation 32(1) on fund usage deviations is not applicable for Q1 FY27.
The company confirms no public, rights, or preferential issues occurred during the qua
